Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China

Asian Journal of Andrology

Volumn 9, Issue 3, 2007, Pages 331-338

  Xu, Zheng ^a   Hua, Li Xin ^a   Qian, Li Xin ^a   Yang, Jie ^a   Wang, Xin Ru ^a   Zhang, Wei ^a   Wu, Hong Fei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genetic susceptibility; Molecular epidemiology; Polymorphism; Prostate cancer; XRCC1

Indexed keywords

ARGININE; GENOMIC DNA; GLUTAMINE; HISTIDINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TRYPTOPHAN; UNCLASSIFIED DRUG; XRCC1 PROTEIN; DNA BINDING PROTEIN; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRINKING; ENVIRONMENTAL EXPOSURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SMOKING; WILD TYPE; ADENOCARCINOMA; BLOOD; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; PROSTATE TUMOR; RISK; RISK FACTOR;

ADENOCARCINOMA; AGED; CHINA; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 34347234210     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2007.00263.x     Document Type: Article

References (19)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
2. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. BJU Int 2002; 90: 162-73.
3. Quinones LA, Irarrazabal CE, Rojas CR, Orellana CE, Acevedo C, Huidobro C, et al. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: An exploratory genotype-environment interaction study. Asian J Androl 2006; 8: 349-55.
4. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. J Natl Cancer Inst 2000; 92: 1764-72.
5. Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002; 23: 1321-5.
6. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 1996; 15: 6662-70.
7. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604-8.
8. Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR, Mullen GP. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol 1999; 6: 884-93.
9. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999; 59: 2557-61.
10. Duell EJ, Wiencke JK, Cheng T J, Varkonyi A, Zuo ZF, Ashok TD, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 965-71.
11. Casse C, Hu YC, Ahrendt SA. The XRCC1 codon 399Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer. Mutat ResM 2003 528: 19-27.
12. Hu JJ, Smith TR, Miller MS, Lohman K, Case LD. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 2002; 39: 208-15.
13. Fan J, Otterlei M, Wong HK, Tomkinson AE, Wilson DM 3rd. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 2004; 32: 2193-201.
14. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 939-43.
15. Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, et al. Genetic variants of DNA repair genes and prostate cancer: A population-based study. Cancer Epidemiol Biomarkers Prev 2005; 14: 1703-9.
16. Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 2006; 175: 108-12.
17. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 2001; 95: 240-6.
18. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003; 12: 1168-74.
19. Olshan AF, Watson MA, Weissler MC, Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002; 178: 181-6.